JP2007501279A5 - - Google Patents

Download PDF

Info

Publication number
JP2007501279A5
JP2007501279A5 JP2006533257A JP2006533257A JP2007501279A5 JP 2007501279 A5 JP2007501279 A5 JP 2007501279A5 JP 2006533257 A JP2006533257 A JP 2006533257A JP 2006533257 A JP2006533257 A JP 2006533257A JP 2007501279 A5 JP2007501279 A5 JP 2007501279A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
group
composition according
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006533257A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007501279A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/015885 external-priority patent/WO2004113320A1/en
Publication of JP2007501279A publication Critical patent/JP2007501279A/ja
Publication of JP2007501279A5 publication Critical patent/JP2007501279A5/ja
Pending legal-status Critical Current

Links

JP2006533257A 2003-05-20 2004-05-20 カンナビノイド誘導体、その製造方法、および使用 Pending JP2007501279A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47231603P 2003-05-20 2003-05-20
PCT/US2004/015885 WO2004113320A1 (en) 2003-05-20 2004-05-20 Cannabinoid derivatives, methods of making, and use thereof

Publications (2)

Publication Number Publication Date
JP2007501279A JP2007501279A (ja) 2007-01-25
JP2007501279A5 true JP2007501279A5 (https=) 2007-08-30

Family

ID=33539041

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006533257A Pending JP2007501279A (ja) 2003-05-20 2004-05-20 カンナビノイド誘導体、その製造方法、および使用

Country Status (10)

Country Link
US (2) US7169942B2 (https=)
EP (1) EP1633733B1 (https=)
JP (1) JP2007501279A (https=)
CN (1) CN1809552A (https=)
AT (1) ATE496901T1 (https=)
AU (1) AU2004249669B2 (https=)
CA (1) CA2526103A1 (https=)
DE (1) DE602004031221D1 (https=)
DK (1) DK1633733T3 (https=)
WO (1) WO2004113320A1 (https=)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1727900A4 (en) * 2004-03-26 2008-05-28 Fujifilm Corp METHOD FOR SELECTIVELY SEPARATING AND CLEANING RNA, AND METHOD FOR SEPARATING AND CLEANING NUCLEIC ACID
US20060257337A1 (en) * 2005-04-28 2006-11-16 David Sherris Compositions and methods to treat skin diseases characterized by cellular proliferation and angiogenesis
USRE46558E1 (en) 2005-04-28 2017-09-26 Paloma Pharmaceuticals, Inc. Compositions and methods to treat diseases characterized by cellular proliferation and angiogenesis
CN102766128A (zh) * 2005-09-29 2012-11-07 阿尔巴尼分子研究公司 δ-9-四氢大麻酚的生成方法
DE102005062098A1 (de) * 2005-12-22 2007-06-28 Merck Patent Gmbh Oxaphenanthren-Derivate
BRPI0708318A2 (pt) * 2006-02-28 2011-05-24 Paloma Pharmaceuticals, Inc. composições e uso de compostos para tratar doenças caracterizadas por proliferação celular e angiogênese
WO2008109027A2 (en) 2007-03-02 2008-09-12 University Of Tennessee Research Foundation, The Tri-aryl/heteroaroaromatic cannabinoids and use thereof
US20110021618A1 (en) * 2008-03-25 2011-01-27 Paloma Pharmaceuticals, Inc. Methods of treating fibrotic disorders
JP2011520972A (ja) * 2008-05-19 2011-07-21 ユニヴァーシティ オブ テネシー リサーチ ファウンデーション，ザ ピリジンの古典的カンナビノイド化合物及び関連する使用方法
US8158654B2 (en) 2008-05-19 2012-04-17 The University Of Tennessee Research Foundation Pyridine non-classical cannabinoid compounds and related methods of use
US8022078B2 (en) * 2008-05-19 2011-09-20 University Of Tennessee Research Foundation Pyrimidine classical cannabinoid compounds and related methods of use
US8476439B2 (en) 2008-05-19 2013-07-02 The University Of Tennessee Research Foundation Pyridine classical cannabinoid compounds and related methods of use
WO2009143183A1 (en) * 2008-05-19 2009-11-26 University Of Tennessee Research Foundation, The Pyrimidine non-classical cannabinoid compounds and related methods of use
US8349876B2 (en) * 2008-05-19 2013-01-08 The University Of Tennesee Research Foundation Pyridine non-classical cannabinoid compounds and related methods of use
US8389534B2 (en) * 2008-05-19 2013-03-05 The University Of Tennessee Research Foundation Pyrimidine non-classical cannabinoid compounds and related methods of use
US9623000B2 (en) 2008-07-31 2017-04-18 Dekel Pharmaceuticals Ltd Compositions and methods for treating inflammatory disorders
WO2012112791A1 (en) 2011-02-16 2012-08-23 Paloma Pharmaceuticals, Inc. Radiation countermeasure agents
CN103110582A (zh) * 2013-03-04 2013-05-22 上海医药工业研究院 大麻酚类化合物微乳剂及其制备方法
US10610512B2 (en) 2014-06-26 2020-04-07 Island Breeze Systems Ca, Llc MDI related products and methods of use
US20170008869A1 (en) * 2015-07-10 2017-01-12 Noramco, Inc. Process for the production of cannabidiol and delta-9-tetrahydrocannabinol
IL248149B (en) * 2016-09-29 2020-03-31 Garti Nissim Dilutable formulations of cannbinoids and processes for their preparation
US10239808B1 (en) 2016-12-07 2019-03-26 Canopy Holdings, LLC Cannabis extracts
US20180169061A1 (en) * 2016-12-15 2018-06-21 Ascent Pharmaceuticals, Inc. Non-aqueous delta9-tetrahydrocannabinol oral liquid formulations
WO2019045994A1 (en) * 2017-08-27 2019-03-07 Rhodes Technologies PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC CONDITIONS
EP3745884A1 (en) 2018-01-31 2020-12-09 Canopy Holdings, Llc Hemp powder
WO2020041322A1 (en) 2018-08-20 2020-02-27 Berkowitz Barry A Novel cannabinoids and cannabinoid acids and their derivatives
CA3119729A1 (en) 2018-10-10 2020-04-16 Treehouse Biotech, Inc. Synthesis of cannabigerol
CN110269839A (zh) * 2019-06-15 2019-09-24 云南飞久逍科技有限公司 一种大麻二酚cbd及其纳米乳在荨麻疹或/和鼻炎制剂中的应用
JP7770688B2 (ja) * 2019-10-03 2025-11-17 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド リポソームカンナビノイドおよびその使用
AU2020377914A1 (en) 2019-11-08 2022-06-02 Vella Bioscience, Inc. Peripherally acting cannabidiol(CBD)-containing compositions and uses thereof for enhancing female sexual function or treating female sexual disorders
US12029718B2 (en) 2021-11-09 2024-07-09 Cct Sciences, Llc Process for production of essentially pure delta-9-tetrahydrocannabinol

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3941782A (en) * 1972-04-27 1976-03-02 Sharps Associates Heterocyclic esters of benzopyrans
US3915996A (en) * 1972-10-16 1975-10-28 Abbott Lab Process for making benzopyrans
US3901926A (en) * 1973-04-02 1975-08-26 Abbott Lab Alkylphenyl benzopyrans
DE4100441A1 (de) * 1991-01-09 1992-07-16 Mack Chem Pharm Verfahren zur herstellung von 6,12-dihydro-6-hydroxy-cannabidiol und dessen verwendung zur herstellung von trans-delta-9-tetrahydrocannabinol
US5596106A (en) * 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists
DE69822449T2 (de) * 1997-01-21 2005-01-27 Smithkline Beecham Corp. Neue cannabinoidrezeptor-modulatoren
FR2758723B1 (fr) * 1997-01-28 1999-04-23 Sanofi Sa Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
DE19706903A1 (de) * 1997-02-21 1998-08-27 Bayer Ag Verwendung von bekannten Agonisten des zentralen Cannabinoid-Rezeptors CB 1
EP0979228A4 (en) * 1997-03-18 2000-05-03 Smithkline Beecham Corp CANNABINOID RECEPTOR AGONISTS
US5939429A (en) * 1997-09-30 1999-08-17 Virginia Commonwealth University Cardiovascular uses of cannabinoid compounds
WO1999057106A1 (en) * 1998-05-04 1999-11-11 The University Of Connecticut Novel analgesic and immunomodulatory cannabinoids
US6563009B1 (en) * 1999-07-12 2003-05-13 Virginia Commonwealth University Vasodilator cannabinoid analogs
FR2799124B1 (fr) * 1999-10-01 2004-08-13 Sanofi Synthelabo Utilisation des antagonistes des recepteurs aux cannabinoides centraux pour la preparation de medicaments
IL132661A (en) * 1999-10-31 2008-11-26 Raphael Mechoulam Agonists specific for peripheral cannabinoid receptors
FR2804604B1 (fr) * 2000-02-09 2005-05-27 Sanofi Synthelabo Utilisation d'un antagoniste des recepteurs aux cannabinoides centraux pour la preparation de medicaments utiles pour faciliter l'arret de la consommation de tabac
US20040039048A1 (en) * 2000-02-11 2004-02-26 Manuel Guzman Pastor Therapy with cannabinoid compounds for the treatment of brain tumors
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
US6448288B1 (en) * 2000-05-17 2002-09-10 University Of Massachusetts Cannabinoid drugs
EP1299374B1 (en) * 2000-06-22 2006-12-27 Pharmos Corporation Novel non-psychotropic cannabinoids
US7507767B2 (en) * 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
US7067539B2 (en) * 2001-02-08 2006-06-27 Schering Corporation Cannabinoid receptor ligands
US6509367B1 (en) * 2001-09-22 2003-01-21 Virginia Commonwealth University Pyrazole cannabinoid agonist and antagonists
RU2004117907A (ru) * 2001-11-14 2006-01-10 Шеринг Корпорейшн (US) Лиганды каннабиноидных рецепторов
MXPA04012704A (es) * 2002-06-19 2005-03-23 Schering Corp Agonistas de los receptores canabinoides.
AU2003267728A1 (en) * 2002-10-18 2004-05-04 Pfizer Products Inc. Cannabinoid receptor ligands and uses thereof

Similar Documents

Publication Publication Date Title
JP2007501279A5 (https=)
TW536534B (en) Difluoroprostaglandin derivatives and pharmaceutical composition comprising them
JP2791544B2 (ja) クロプロステノール及びフルプロステノールの各類似体
JP6065052B2 (ja) テトラヒドロカルボリン誘導体
US20180116995A1 (en) Bicyclic compound and use thereof for medical purposes
WO1998034916A1 (fr) Derives de 11,15-o-dialkylprostaglandine e, leur procede de production, et medicaments renfermant ceux-ci comme principe actif
CN115160339B (zh) 醛糖还原酶抑制剂及其使用方法
AU1976000A (en) Nonsteroidal antiinflammatories
JPWO1998034916A1 (ja) １１，１５−ｏ−ジアルキルプロスタグランジンｅ誘導体、それらの製造方法およびそれらを有効成分として含有する薬剤
AU609139B2 (en) Anti-inflammatory furanones
US20030083508A1 (en) Method for the preparation of citalopram
JP2002509543A (ja) 緑内障の治療のための副作用のないプロスタグランジン誘導体
JP2011037861A (ja) Ｃ１６不飽和ｆｐ−選択的プロスタグランジン類縁体
JP2002543114A5 (https=)
JPH06507608A (ja) ベンゾフラン誘導体
EP2669280B1 (en) Bicyclic compound and use thereof for medical purposes
JP2000505448A (ja) カンプトテシン誘導体及び抗腫瘍剤としてのその利用
WO1998057930A1 (en) Keto-substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives
EP0818439B1 (en) Imide derivatives
JP2006506381A5 (https=)
JPH037275A (ja) ２，５，６，７―テトラノル―４，８―インタ―ｍ―フェニレンＰＧＩ↓２誘導体
CA2259585A1 (en) Benzimidazole derivatives having eosinophil increment inhibition activity and their use as medicament
JPH06505698A (ja) 新規化合物
JPH1072421A (ja) イミド誘導体
CN111662239A (zh) 1,2,4-三唑类化合物及其制法和药物用途